These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11795348)

  • 1. Capitalizing on the complexities of estrogen receptor pharmacology in the quest for the perfect SERM.
    McDonnell DP; Chang CY; Norris JD
    Ann N Y Acad Sci; 2001 Dec; 949():16-35. PubMed ID: 11795348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidation of the molecular mechanism of action of selective estrogen receptor modulators.
    McDonnell DP; Wijayaratne A; Chang CY; Norris JD
    Am J Cardiol; 2002 Jul; 90(1A):35F-43F. PubMed ID: 12106639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definition of the molecular and cellular mechanisms underlying the tissue-selective agonist/antagonist activities of selective estrogen receptor modulators.
    McDonnell DP; Connor CE; Wijayaratne A; Chang CY; Norris JD
    Recent Prog Horm Res; 2002; 57():295-316. PubMed ID: 12017549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 27-hydroxycholesterol is an endogenous selective estrogen receptor modulator.
    DuSell CD; Umetani M; Shaul PW; Mangelsdorf DJ; McDonnell DP
    Mol Endocrinol; 2008 Jan; 22(1):65-77. PubMed ID: 17872378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From empirical to mechanism-based discovery of clinically useful Selective Estrogen Receptor Modulators (SERMs).
    Wardell SE; Nelson ER; McDonnell DP
    Steroids; 2014 Nov; 90():30-8. PubMed ID: 25084324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of selective estrogen receptor modulator (SERM) action.
    Dutertre M; Smith CL
    J Pharmacol Exp Ther; 2000 Nov; 295(2):431-7. PubMed ID: 11046073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular mechanisms underlying the pharmacological actions of ER modulators: implications for new drug discovery in breast cancer.
    McDonnell DP; Wardell SE
    Curr Opin Pharmacol; 2010 Dec; 10(6):620-8. PubMed ID: 20926342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective estrogen receptor modulators: an update on recent clinical findings.
    Shelly W; Draper MW; Krishnan V; Wong M; Jaffe RB
    Obstet Gynecol Surv; 2008 Mar; 63(3):163-81. PubMed ID: 18279543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Selective estrogen receptor modulators: mechanisms of action and their tissue selectivity].
    Azuma K; Inoue S
    Clin Calcium; 2004 Oct; 14(10):12-26. PubMed ID: 15577127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designing the ideal selective estrogen receptor modulator--an achievable goal?
    Taylor HS
    Menopause; 2009; 16(3):609-15. PubMed ID: 19182697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular perspectives on selective estrogen receptor modulators (SERMs): progress in understanding their tissue-specific agonist and antagonist actions.
    Lonard DM; Smith CL
    Steroids; 2002 Jan; 67(1):15-24. PubMed ID: 11728517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research resource: Transcriptional profiling in a cellular model of breast cancer reveals functional and mechanistic differences between clinically relevant SERM and between SERM/estrogen complexes.
    Wardell SE; Kazmin D; McDonnell DP
    Mol Endocrinol; 2012 Jul; 26(7):1235-48. PubMed ID: 22570330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen but not other selective estrogen receptor modulators antagonizes estrogen actions on luteinizing hormone secretion while inducing gonadotropin-releasing hormone self-priming in the rat.
    Sánchez-Criado JE; Guelmes P; Bellido C; Gónzalez M; Hernández G; Aguilar R; Garrido-Gracia JC; Bello AR; Alonso R
    Neuroendocrinology; 2002 Oct; 76(4):203-13. PubMed ID: 12411737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an ER action indicator mouse for the study of estrogens, selective ER modulators (SERMs), and Xenobiotics.
    Nagel SC; Hagelbarger JL; McDonnell DP
    Endocrinology; 2001 Nov; 142(11):4721-8. PubMed ID: 11606437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding capacity of ER-α ligands and SERMs: comparison of the human, dog and cat.
    Toniti W; Suthiyotha N; Puchadapirom P; Jenwitheesuk E
    Asian Pac J Cancer Prev; 2011; 12(11):2875-9. PubMed ID: 22393957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oestrogens and selective oestrogen receptor (ER) modulators regulate EGF receptor gene expression through human ER alpha and beta subtypes via an Sp1 site.
    Salvatori L; Pallante P; Ravenna L; Chinzari P; Frati L; Russo MA; Petrangeli E
    Oncogene; 2003 Jul; 22(31):4875-81. PubMed ID: 12894229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetrahydroquinoline-based selective estrogen receptor modulators (SERMs).
    Wallace OB; Lauwers KS; Jones SA; Dodge JA
    Bioorg Med Chem Lett; 2003 Jun; 13(11):1907-10. PubMed ID: 12749895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular simulation of interaction between estrogen receptor and selective estrogen receptor modulators.
    Guo ZR; Yi X; Xu ZB
    Acta Pharmacol Sin; 2002 Mar; 23(3):208-12. PubMed ID: 11918843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective estrogen receptor modulators (SERMs): A first step in the development of perfect hormone replacement therapy regimen.
    McDonnell DP
    J Soc Gynecol Investig; 2000; 7(1 Suppl):S10-5. PubMed ID: 10732322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogens and SERMs in coronary heart disease.
    Regitz-Zagrosek V; Wintermantel TM; Schubert C
    Curr Opin Pharmacol; 2007 Apr; 7(2):130-9. PubMed ID: 17317318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.